REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT03294083 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. start date: 2018-06-07 → 2018-06-19 3. completion date: 2023-11-01 → 2023-02-16 4. primary completion date: 2023-08-01 → 2023-02-16 5. enrollment: 89 → 95 participants
📉 **NEGATIVE** • Medium confidence analysis (73%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (18%) **Content type:** Clinical